Filing Details
- Accession Number:
- 0001209191-22-029091
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-16 14:13:24
- Reporting Period:
- 2022-05-12
- Accepted Time:
- 2022-05-16 14:13:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1703057 | Abcellera Biologics Inc. | ABCL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1834411 | Andrew Booth | C/O Abcellera Biologics Inc. 2215 Yukon Street Vancouver A1 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2022-05-12 | 85,000 | $5.79 | 138,500 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares | 130,959 | Indirect | By spouse |
Billionaire Hedge Funds
